Open forum infectious diseases
Early Experience and Effectiveness of Long-Acting Injectable Cabotegravir and Rilpivirine in a South Side Chicago HIV Clinic.
Reply: "Continuing the Chat: How Can We Improve the Performance of an Artificial Intelligence Chatbot in Answering Clinical Infectious Diseases Pharmacotherapy Questions?"
P-974. An Embedded Transplant Infectious Diseases Fellowship Track Is Appealing to Clinical and Research-Focused Fellows.
P-741. Dalbavancin Rationale and Clinical Outcomes in Patients Hospitalized with Serious Bacterial Infections at an Urban Safety Net Hospital: an Observational Cohort.
P-2201. A Comprehensive Kidney Biomarker Panel to Assess Kidney Health after Hepatitis C Direct Acting Antiviral Therapy in Persons with HCV monoinfection and HCV/HIV coinfection.
P-2342. Dynamics of indirect protection against SARS-CoV-2 infection through vaccine- and infection-acquired immunity.
P-2320. Clinical Significance of Colonization with Fluoroquinolone-Resistant Enterobacterales in Hematopoietic Cell Transplant Recipients and Patients with Acute Leukemia.
P-1559. Comparing Patient and Clinician Perceptions of Health-Related Quality of Life in Hospitalized Patients with Complicated Urinary Tract Infections: A Qualitative Descriptive Study.
84. Improving Traditional Registrational Trial Endpoints: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Acute Bacterial Skin and Skin-Structure Infections.
299. Metagenomic Next-Generation Sequencing of Cerebrospinal Fluid for Central Nervous System Infections: Clinical Factors Associated with Increased Diagnostic Yield.
